OTSUKA AMERICA PHARMACEUTICAL

- Charles "Chuck" Leitgeb, Deputy Director of State Government Relations at Bayer US, was elected Chair of the HINJ Board of Trustees, effective July 1, 2026. - Adam Brand of Otsuka America Pharmaceutical was elected Vice Chair, with Christopher Guiton (Johnson & Johnson) as Treasurer and Derek Naten (Keenova Therapeutics) as Secretary. - Adam Taliaferro of Johnson & Johnson was reappointed Chair of the HINJ Steering Committee, with George Coutros of Sanofi US reappointed as Vice Chair. - The board includes senior government affairs leaders from major pharmaceutical companies including Novo Nordisk, Merck, BD, Novartis, and Daiichi Sankyo.

Jul 22, 2026

Back to Organizations

OTSUKA AMERICA PHARMACEUTICAL

Overview

Trial Phase Distribution

Trial Status Distribution

Clinical Trials

Trials sponsored by this organization (13)

POCone-UBiT-IR300 Pediatric Comparison Study

Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia

Study for the Treatment of Crohn's Disease With Adacolumn

Study for the Treatment of Ulcerative Colitis With Adacolumn

Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon

Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon

A Long-Term, Follow-On Safety Study of Four Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons

A Phase I Study of Three Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons With CD4+ Cell Number > 300 Cells/mm3

Approvals

Approvals by Agency

Recent Approvals

News

HealthCare Institute of New Jersey Elects Bayer's Chuck Leitgeb as Board Chair